公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Mining Health Social Media with Sentiment Analysis | Yang F.-C.; Lee A.J.T. ; Kuo S.-C. | Journal of Medical Systems | 47 | 31 | |
2006 | Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b] quinoline-3,4-dione] in guinea pig cardiac preparations | Chang G.-J.; MING-JAI SU ; Kuo S.-C.; Lin T.-P.; Lee Y.-S. | Journal of Pharmacology and Experimental Therapeutics | 6 | 6 | |
2021 | Nonpolio enterovirus activity during the COVID-19 Pandemic, Taiwan, 2020 | Kuo S.-C.; Tsou H.-H.; Wu H.-Y.; Hsu Y.-T.; Lee F.-J.; Shih S.-M.; Hsiung C.A.; WEI J. CHEN | Emerging Infectious Diseases | 10 | 10 | |
2010 | A novel compound, NP-184, inhibits the vascular endothelial growth factor induced angiogenesis | Lin K.-T.; Lien J.-C.; Chung C.-H.; Kuo S.-C.; TUR-FU HUANG | European Journal of Pharmacology | 22 | 20 | |
2015 | Novel Pyrazole Derivatives Effectively Inhibit Osteoclastogenesis, a Potential Target for Treating Osteoporosis | Kuo T.-H.; Lin T.-H.; RONG-SEN YANG ; Kuo S.-C.; WEN-MEI FU ; Hung H.-Y. | Journal of Medicinal Chemistry | 15 | 15 | |
2016 | A novel thromboxane receptor antagonist, nstpbp5185, inhibits platelet aggregation and thrombus formation in animal models | Huang S.-W.; Kuo H.-L.; Hsu M.-T.; YUFENG JANE TSENG ; SHU-WHA LIN ; Kuo S.-C.; Peng H.-C.; Lien J.-C.; TUR-FU HUANG | Thrombosis and Haemostasis | 11 | | |
2010 | NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities | Kuo H.-L.; Lien J.-C.; Chung C.-H.; Chang C.-H.; SHYH-CHYI LO ; Tsai I.-C.; Peng H.-C.; Kuo S.-C.; TUR-FU HUANG | Naunyn-Schmiedeberg's Archives of Pharmacology | 29 | 23 | |
2011 | NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A 2 synthesis and calcium entry | Kuo H.-L.; Lien J.-C.; Chang C.-H.; Chung C.-H.; Kuo S.-C.; Hsu C.-C.; Peng H.-C.; TUR-FU HUANG | British Journal of Pharmacology | 5 | 6 | |
2005 | A potential role of YC-I on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models | Pan S.-L.; JIH-HWA GUH ; Peng C.-Y.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-H. | Thrombosis and Haemostasis | 32 | 31 | |
2015 | A proposed mother-friendly childbirth model for Taiwanese women and obstetricians' attitudes toward it | Li Y.-P.; SHIN-YU LIN ; Yeh C.-H.; HENG-CHENG HSU ; YA-LING YANG ; CHIEN-NAN LEE ; Kuo S.-C. | Taiwanese Journal of Obstetrics and Gynecology | 2 | 1 | |
2015 | A proposed mother-friendly childbirth model for Taiwanese women, the implementation and satisfaction survey | Li Y.-P; Yeh C.-H; SHIN-YU LIN ; TAI-CHANG CHEN ; YA-LING YANG ; CHIEN-NAN LEE ; Kuo S.-C. | Taiwanese journal of obstetrics & gynecology | 5 | 2 | |
2007 | Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways | Chen Y.-C.; Lu P.-H.; Pan S.-L.; Teng C.-M.; Kuo S.-C.; Lin T.-P.; Ho Y.-F.; Huang Y.-C.; JIH-HWA GUH | Biochemical Pharmacology | 58 | 59 | |
2014 | Sheltering effect and indirect pathogenesis of carbapenem-resistant Acinetobacter baumannii in polymicrobial infection | Liao Y.-T.; Kuo S.-C.; Lee Y.-T.; Chen C.-P.; SHU-WEN LIN ; LI-JIUAN SHEN ; Fung C.-P.; Cho W.-L.; Chen T.-L. | Antimicrobial Agents and Chemotherapy | 35 | 34 | |
2020 | Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation | Juang S.-H.; Hsieh M.-T.; Hsu P.-L.; Chen J.-L.; Liu H.-K.; Liang F.-P.; Kuo S.-C.; Chiu C.-Y.; SHING-HWA LIU ; Chou C.-H.; Wu T.-S.; Hung H.-Y. | Molecules (Basel, Switzerland) | 3 | 3 | |
2015 | Suramin inhibits chikungunya virus entry and transmission | Ho Y.-J.; Wang Y.-M.; Lu J.-W.; Wu T.-Y.; LIANG-IN LIN ; Kuo S.-C.; Lin C.-C. | PLoS ONE | 59 | 52 | |
2008 | Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents | Lien J.-C.; Wu C.-R.; Hour M.-J.; Huang L.-J.; TUR-FU HUANG ; Kuo S.-C. | Archiv der Pharmazie | 3 | 3 | |
2005 | YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G 0-G1 in human hepatocellular carcinoma cells | Wang S.-W.; Pan S.-L.; JIH-HWA GUH ; Chen H.-L.; Huang D.-M.; Chang Y.-L.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Journal of Pharmacology and Experimental Therapeutics | 47 | 47 | |
2005 | YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models | Pan S.-L.; JIH-HWA GUH ; Peng C.-Y.; Wang S.-W.; Chang Y.-L.; Cheng F.-C.; Chang J.-H.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Journal of Pharmacology and Experimental Therapeutics | 55 | 53 | |
2006 | YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9 | Liu Y.-N.; Pan S.-L.; Peng C.-Y.; JIH-HWA GUH ; Huang D.-M.; Chang Y.-L.; Lin C.-H.; Pai H.-C.; Kuo S.-C.; Lee F.-Y.; Teng C.-M. | Journal of Pharmacology and Experimental Therapeutics | 39 | 33 | |
2007 | YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-κB in microglia | Lu D.-Y.; Tang C.-H.; Liou H.-C.; Teng C.-M.; Jeng K.-C.G.; Kuo S.-C.; Lee F.-Y.; WEN-MEI FU | British Journal of Pharmacology | 57 | 55 | |